Comaprison of 2 drugs (bupivacaine and ropivacaine) in spinal anaesthesia for planned caesarean delivery.

Comparison of hyperbaric ropivacaine (0.75%) and hyperbaric bupivacaine (0.5%) in spinal anaesthesia for lower segment caesarean section: a randomized double blind study. - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056912

Enrollment

Registered

2023-08-24

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: 1- Obstetrics Health Condition 3: O269- Pregnancy related conditions, unspecified

Interventions

Intervention1: Ropivacaine vs bupivacaine: Comparison of intrathecal hyperbaric ropivacaine(0.75%)-2ml and hyperbaric bupivacaine(0.5%)-2ml in lower segment caesarean section Control Intervention1: Hy

Eligibility

Inclusion criteria

Inclusion criteria: age 18-40 years ASA physical status II ( uncomplicated pregnancy comes in ASAII) Full term parturients scheduled for elective and semielective LSCS under spinal anaesthesia for indications like previous LSCS, primi breech, postdatism, cord around neck, cephalopelvic disproportion, non progress of labour. Height -150-170 cm Weight 45-90 kg

Exclusion criteria

Exclusion criteria: Patient refusal Patient with contraindication to spinal anaesthesia like coagulopathies or anticoagulant medication, raised intracranial pressure, local puncture site infection, etc Any cardiac,neurological, renal ,liver, endocrine,haematological or any coexisting systemic medical comorbidity, short stature, obesity (BMI more than 30kg/m2) Difficult airway, kyphoscoliosis, prior spine surgery. Emergency LSCS. Any obstetric comorbidity like antepartum haemorrhage, pregnancy induced hypertension, gestational diabetes etc. History of allergy to study drugs.

Design outcomes

Primary

Measure	Time frame
Duration of motor blockade.Timepoint: Upto 3 hours postoperatively	—

Secondary

Measure	Time frame
Intraoperative haemodynamics & side effectsTimepoint: Upto 24 hours postoperatively	—

Countries

India

Contacts

Public ContactDr Isha Garg

Dept of Anaesthesiology,Rabindranath Tagore Medical College , Udaipur

uditanaithani@gmail.com9829414752

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026